semaglutide elisa cross reactivity liraglutide Targeting GLP-1 receptor trafficking to improve agonist efficacy Spotlight on the Mechanism of

The available human data is mainly from small observational and retrospective studies showing that GLP-1 drugs appear safe and well tolerated in people with MS when used for diabetes or weight loss

Clinical trials have demonstrated that high-dose oral semaglutide is highly effective for weight loss, rivaling the results of the popular 2.4 mg weekly injection

Abbreviations ARIC: Atherosclerosis Risk in Communities ASCVD: Atherosclerotic CVD CKD: Chronic kidney disease FG: Fasting glucose GLP-1: Glucagon-like peptide 1 SGLT-2: Sodiumglucose cotransporter 2 inhibitor References Centers for Disease Control and prevention (2024) National Diabetes Statistics Report

While they work in similar ways, there are a few key differences between each drug or brand that could impact whether these medications are a good option for you

" For months these have been my daily go-to